Crescita Therapeutics Inc. (TSX: CTX)

Crescita Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12	10	13	14	14	19
Market Cap Growth	-22.04%	-27.40%	-1.08%	-5.64%	-25.07%	106.27%
Enterprise Value	4	1	4	4	2	11
Last Close Price	0.64	0.49	0.66	0.65	0.70	0.93
PE Ratio	-	-4.90	16.50	-12.21	396.83	10.75
PS Ratio	0.75	0.56	0.57	0.81	0.92	0.86
PB Ratio	0.72	0.52	0.64	0.66	0.68	0.91
P/FCF Ratio	-40.25	5.04	-10.80	-7.02	2.60	3.79
P/OCF Ratio	13.06	4.72	-13.23	-8.54	2.58	3.64
EV/Sales Ratio	0.26	0.06	0.19	0.26	0.12	0.51
EV/EBITDA Ratio	-0.86	-1.26	2.71	-8.95	0.92	1.78
EV/EBIT Ratio	-0.59	-0.55	8.26	-2.87	2.22	2.29
EV/FCF Ratio	-17.30	0.56	-3.50	-2.21	0.33	2.24
Debt / Equity Ratio	0.06	0.07	0.08	0.14	0.06	0.07
Debt / EBITDA Ratio	-	-	0.81	-	0.53	0.23
Debt / FCF Ratio	-4.05	0.65	-1.29	-1.48	0.22	0.30
Asset Turnover	0.68	0.66	0.82	0.60	0.58	0.82
Inventory Turnover	1.44	1.22	2.06	1.72	1.21	1.79
Quick Ratio	2.23	2.50	2.40	2.25	3.41	2.74
Current Ratio	3.37	3.80	3.39	2.99	4.21	3.67
Return on Equity (ROE)	-15.79%	-9.95%	4.14%	-5.30%	0.18%	9.25%
Return on Assets (ROA)	-8.26%	-4.61%	1.15%	-3.35%	1.94%	11.41%
Return on Capital (ROIC)	-10.16%	-5.71%	1.43%	-4.09%	2.31%	13.48%
Earnings Yield	-23.49%	-20.28%	6.39%	-8.10%	0.26%	9.62%
FCF Yield	-2.06%	19.84%	-9.26%	-14.25%	38.39%	26.39%
Buyback Yield / Dilution	4.26%	3.55%	-1.18%	1.02%	6.79%	-14.16%
Total Shareholder Return	4.26%	3.55%	-1.18%	1.02%	6.79%	-14.16%

Source: S&P Capital IQ. Standard template. Financial Sources.